Amberstone Biosciences Inc
- Biotech or pharma, therapeutic R&D
Amberstone Bio is advancing a Next Generation of Conditionally Active T-cell Engagers (TCEs) and PD1 x IL-12 bifunctional protein targeting major opportunities in oncology. Our conditional molecules are each precision-engineered to ensure a superior efficacy/safety balance while maintaining robust developability and manufacturability. We are actively exploring partnerships (collaborations and/or out-licensing) and investment opportunities.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}